Chanelle Shortlisted for Prestigious Pharma Awards

Chanelle are delighted to announce the company has been shortlisted in the 2016 Pharma Company of the Year Awards (Large) in Ireland.

Commenting on the announcement, Michael Burke, MD said, “Our customers are the foundation of our success and I would like to take this opportunity to sincerely thank them for their continuous support and encouragement.”

Chanelle are shortlisted for Pharma Company of the Year among the following companies;


-Chanelle Group



The company is also shortlisted for Pharma Project of the Year for their development of super generic, Rheumocam® (Meloxicam) Granules –  a new formulation of an existing molecule, Meloxicam.

The shortlist for Pharma Project of the Year is as follows;

-Bristol-Myers Squibb – External Manufacturing

-Chanelle Group

-Janssen Biologics

An independent panel of recognised and expert judges representing the Pharma industry will assess all applications and determine the winners at an Awards Ceremony in Dublin on October 13th 2016. For more information visit

Chanelle would like to wish all the nominees the best of luck.